Skip to content

The Effect of the Hydroxyethyl Starch on Kidney Injury in Pediatric Cardiac Surgery

The Effect of the Hydroxyethyl Starch on Kidney Injury in Pediatric Cardiac Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02599155
Enrollment
200
Registered
2015-11-06
Start date
2015-11-30
Completion date
2016-03-31
Last updated
2017-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Keywords

crystalloid, colloid, children, infant, cardiac surgery

Brief summary

The investigator will evaluate the influence of colloid administration on postoperative acute kidney injury in pediatric patients undergoing cardiac surgery under cardiopulmonary bypass.

Detailed description

The investigator will randomly divide pediatric patients aged less than 7 years old into crystalloid and colloid groups. Crystalloid group receive only crystalloid, and colloid group receive hydroxyethyl starch (HES, 130/0.4). The maximum volume of HES is limited less than 30 ml/kg. The same transfusion protocol will be applied in both groups. From the day of operation to postoperative 7 days, glomerular filtration rate (GFR), serum creatinin level (Cr) will be checked. Acute kidney injury (AKI) is defined when there is more than 50% increase in Cr when compared to baseline level. The investigator will compare the clinical outcomes including AKI between two groups.

Interventions

normal saline administration for volume expansion in hypovolemic status

HES 130/0.4 administration for volume expansion in hypovolemic status

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
No minimum to 7 Years
Healthy volunteers
Yes

Inclusion criteria

* Children aged less than 7 years old * American Society of Anesthesiology (ASA) physical status 1-3

Exclusion criteria

* Preoperative creatinine \> 1.5mg/dl * History of dialysis * Liver function abnormality * Diabetes Mellitus * History of allergic reaction * Coagulation abnormality

Design outcomes

Primary

MeasureTime frame
Acute Kidney InjuryFrom the day of surgery to postoperative 7 days

Secondary

MeasureTime frame
Blood lossFrom the day of surgery to postoperative 7 days
Transfusion amountFrom the day of surgery to postoperative 7 days
Mechanical ventilation timeFrom the day of surgery to postoperative 7 days
Length of ICU stayFrom the day of surgery to postoperative 7 days

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026